Indian American Scientist Wins Harrington Prize 2026
Indian American physician-scientist Dr Arul Chinnaiyan has been jointly awarded the 13th Harrington Prize for Innovation in Medicine, alongside Dr Charles L Sawyers, in recognition of their groundbreaking contributions to prostate cancer research and precision oncology. The award highlights their transformative work that has reshaped the understanding, diagnosis, and treatment of prostate cancer worldwide.
The Harrington Prize, established in 2014 by the Harrington Discovery Institute in collaboration with the American Society for Clinical Investigation, honors physician-scientists whose work demonstrates exceptional innovation with strong clinical impact. The 2026 recognition celebrates discoveries that have directly influenced modern cancer care.
Dr Chinnaiyan, an investigator at the Howard Hughes Medical Institute and professor of pathology at the University of Michigan Medical School, is widely known for identifying the TMPRSS2-ERG gene fusion. This genetic alteration is one of the most common drivers of prostate cancer and has become a key biomarker in diagnostic research.
His co-recipient, Dr Charles Sawyers of Memorial Sloan Kettering Cancer Center, is recognized for developing advanced androgen receptor inhibitors such as enzalutamide and apalutamide, both of which are widely used FDA-approved treatments for prostate cancer. His earlier research also contributed to the development of imatinib, a breakthrough drug that revolutionized treatment for chronic myeloid leukemia.
Together, the two scientists have also played a major role in identifying genetic mutations in advanced prostate cancer that respond to PARP inhibitors like olaparib, further expanding targeted treatment options for patients. Their combined research has helped establish the foundation of modern precision medicine in prostate cancer care.
The award committee noted that their discoveries have fundamentally changed how prostate cancer is understood at the molecular level and how it is treated in clinical practice. Their work has significantly improved survival outcomes and continues to guide next-generation therapies.
Indian American representation in global medical research is highlighted through Dr Chinnaiyan’s achievement, reflecting the growing influence of diaspora scientists in advancing cutting-edge biomedical innovation. His work continues to bridge laboratory research and clinical application, strengthening the global fight against cancer.
As part of the honor, the recipients will deliver the Harrington Prize Lecture at the 2026 AAP/ASCI/APSA Joint Meeting and participate in the Harrington Scientific Symposium. They will also contribute a scholarly essay to the Journal of Clinical Investigation, further sharing their insights with the global medical community.
The recognition places Dr Chinnaiyan among a distinguished group of past laureates who have made landmark contributions to medicine, reinforcing the importance of scientific discovery in transforming patient care worldwide.
